1G7O

NMR SOLUTION STRUCTURE OF REDUCED E. COLI GLUTAREDOXIN 2

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D_13C-separated_NOESY	2mM glutaredoxin 2; U-15N,13C; 50mM phosphate buffer;	90% H2O/10% D2O		7.0	1 atm	293
2	3D_15N-separated_NOESY	2mM glutaredoxin 2; U-15N,13C; 50mM phosphate buffer;	90% H2O/10% D2O		7.0	1 atm	293
3	4D_13C/15N-separated_NOESY	2mM glutaredoxin 2; U-15N,13C; 50mM phosphate buffer;	90% H2O/10% D2O		7.0	1 atm	293
4	HNHA	2mM glutaredoxin 2; U-15N,13C; 50mM phosphate buffer;	90% H2O/10% D2O		7.0	1 atm	293

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DMX	750
2	Bruker	DRX	600

NMR Refinement
Method	Details	Software
torsion angle dynamics, simulated annealing, molecular dynamics		Felix

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations,structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	21
Representative Model	21 (minimized average structure)

Additional NMR Experimental Information
Details	The structure was determined using triple-resonance NMR spectroscopy.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	Felix	98
2	structure solution	DYANA
3	structure solution	Amber
4	refinement	Amber

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.